Adjuvant Holdings Co.,Ltd. (TYO:4929)
741.00
+1.00 (0.14%)
Jul 31, 2026, 3:30 PM JST
Adjuvant Holdings Revenue
Adjuvant Holdings had revenue of 1.05B JPY in the quarter ending June 20, 2026, with 9.71% growth. This brings the company's revenue in the last twelve months to 3.91B, down -2.20% year-over-year. In the fiscal year ending March 20, 2026, Adjuvant Holdings had annual revenue of 3.81B, down -6.95%.
Revenue (ttm)
3.91B
Revenue Growth
-2.20%
P/S Ratio
1.52
Revenue / Employee
31.76M
Employees
123
Market Cap
5.93B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 20, 2026 | 3.81B | -285.00M | -6.95% |
| Mar 20, 2025 | 4.10B | -340.00M | -7.66% |
| Mar 20, 2024 | 4.44B | 61.00M | 1.39% |
| Mar 20, 2023 | 4.38B | -50.00M | -1.13% |
| Mar 20, 2022 | 4.43B | -458.00M | -9.38% |
| Mar 20, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 20, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 20, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 20, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 20, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Niitaka | 24.62B |
| SHOBIDO | 22.85B |
| Nippon Shikizai | 17.18B |
| Premier Anti-Aging | 14.25B |
| AXXZIA | 13.29B |
| HABA Laboratories,Inc. | 12.14B |
| Kitanotatsujin | 11.82B |
| Liberta | 10.29B |